Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: Implications for prophylactic surgery

Breast Cancer Research and Treatment

Volumn 135, Issue 3, 2012, Pages 781-789

  Miller, Cynthia L ^a   Specht, Michelle C ^a   Skolny, Melissa N ^a   Jammallo, Lauren S ^a   Horick, Nora ^a   O'Toole, Jean ^a   Coopey, Suzanne B ^a   Hughes, Kevin ^a   Gadd, Michele ^a   Smith, Barbara L ^a   Taghian, Alphonse G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Arm swelling; Bilateral mastectomy; Breast cancerrelated lymphedema; Prophylactic mastectomy; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARM; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTECTOMY; MEASUREMENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPHYLACTIC MASTECTOMY; PROPHYLAXIS; PROSPECTIVE STUDY; QUESTIONNAIRE; SENTINEL LYMPH NODE BIOPSY; SYMPTOM;

ADULT; AGED; ARM; AXILLA; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHEDEMA; MASTECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREVENTIVE MEDICINE; PROSPECTIVE STUDIES; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; YOUNG ADULT;

EID: 84866565220     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2231-1     Document Type: Article

References (49)

1. Schrag D, Kuntz KM, Garber JE, Weeks JC (2000) Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA 283(5): 617-624. doi:10.1001%2Fjama.283.5.617 (Pubitemid 30069177)
2. Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, Virnig BA (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27(9):1362-1367. doi:10.1200/JCO.2008.20. 1681
3. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25(33):5203-5209. doi:10.1200/ JCO.2007.12.3141 (Pubitemid 350232251)
4. McDonnell SK, Schaid DJ, Myers JL, Grant CS, Donohue JH, Woods JE, Frost MH, Johnson JL, Sitta DL, Slezak JM, Crotty TB, Jenkins RB, Sellers TA, Hartmann LC (2001) Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 19(19):3938-3943 (Pubitemid 32912020)
5. Herrinton LJ, Barlow WE, Yu O, Geiger AM, Elmore JG, Barton MB, Harris EL, Rolnick S, Pardee R, Husson G, Macedo A, Fletcher SW (2005) Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 23(19):4275-4286. doi:10.1200/JCO.2005. 10.080 (Pubitemid 46207002)
6. Yao K, Stewart AK, Winchester DJ, Winchester DP (2010) Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol 17(10):2554-2562. doi:10.1245/s10434-010-1091-3
7. Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106(1):4-16. doi:10.1002/cncr.21568 (Pubitemid 43033320)
8. Boughey JC, Khakpour N, Meric-Bernstam F, Ross MI, Kuerer HM, Singletary SE, Babiera GV, Arun B, Hunt KK, Bedrosian I (2006) Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 107(7):1440-1447. doi: 10.1002/cncr.22176 (Pubitemid 44546902)
9. Dupont EL, Kuhn MA, McCann C, Salud C, Spanton JL, Cox CE (2000) The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 180(4):274-277
10. McLaughlin SA, Stempel M, Morris EA, Liberman L, King TA (2008) Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy? Cancer 112(6):1214-1221. doi:10.1002/cncr. 23298 (Pubitemid 351429736)
11. Laronga C, Lee MC, McGuire KP, Meade T, Carter WB, Hoover S, Cox CE (2009) Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy. J Am Coll Surg 209(6):746-752; quiz 800-741. doi:10.1016/j. jamcollsurg.2009. 08.010
12. Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, Gabram SG, Lucci A, Cox CE, Hunt KK, Herndon JE II, Giuliano AE (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13(4):491-500. doi:10.1245/ASO.2006.05.013
13. Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25(24):3657-3663. doi:10.1200/JCO.2006.07.4062 (Pubitemid 47372604)
14. McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. doi:10.1200/JCO.2008. 16.3766
15. Baron RH, Fey JV, Borgen PI et al (2007) Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Ann Surg Oncol 14(5):1653-1661 (Pubitemid 46791011)
16. Haid A, Kuehn T, Konstantiniuk P, Koberle-Wuhrer R, Knauer M, Kreienberg R, Zimmermann G (2002) Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 28(7):705-710. doi:10.1053/ ejso.2002.1327 (Pubitemid 36240568)
17. Golshan M, Martin WJ, Dowlatshahi K (2003) Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 69(3):209-211 discussion 212
18. Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95(3):279-293. doi:10.1007/ s10549-005-9025-7
19. Temple LK, Baron R, Cody HS III, Fey JV, Thaler HT, Borgen PI, Heerdt AS, Montgomery LL, Petrek JA, Van Zee KJ (2002) Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 9(7):654-662 (Pubitemid 34857982)
20. Ronka R, von Smitten K, Tasmuth T, Leidenius M (2005) Oneyear morbidity after sentinel node biopsy and breast surgery. Breast 14(1):28-36. doi:10.1016/j.breast.2004.09.010 (Pubitemid 40197824)
21. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98(9):599-609. doi:10.1093/jnci/djj158 (Pubitemid 43904843)
22. Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK, Hess T, Oertli D, Bronz L, Schnarwyler B, Wight E, Uehlinger U, Infanger E, Burger D, Zuber M (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245(3):452-461. doi:10.1097/01.sla.0000245472. 47748.ec (Pubitemid 46673142)
23. McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. doi:10.1200/JCO.2008.16.3725
24. Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, Groothoff JW, Eisma WH, Dijkstra PU (2006) Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 32(2):148-152. doi:10.1016/j.ejso.2005.11. 008 (Pubitemid 43257114)
25. Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A (2006) Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 93(2):109-119. doi:10.1002/ jso.20406 (Pubitemid 43235256)
26. Cormier JN, Xing Y, Zaniletti I, Askew RL, Stewart BR, Armer JM (2009) Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology 42(4):161-175
27. Armer JM, Radina ME, Porock D, Culbertson SD (2003) Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 52(6):370-379
28. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B (2008) Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 26(21):3536-3542. doi:10.1200/JCO.2007.14.4899
29. Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR (2008) Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. J Clin Oncol. doi:10.1200/ JCO.2008.16.4731
30. Sakorafas GH, Peros G, Cataliotti L, Vlastos G (2006) Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15(3):153-165. doi:10.1016/j.suronc.2006. 11.003 (Pubitemid 46241869)
31. Jager G, Doller W, Roth R (2006) Quality-of-life and body image impairments in patients with lymphedema. Lymphology 39(4):193-200 (Pubitemid 46147799)
32. Ancukiewicz M, Russell TA, Otoole J, Specht M, Singer M, Kelada A, Murphy CD, Pogachar J, Gioioso V, Patel M, Skolny M, Smith BL, Taghian AG (2011) Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 79(5):1436-1443. doi:10.1016/j.ijrobp.2010.01.001
33. Mahamaneerat WK, Shyu CR, Stewart BR, Armer JM (2008) Breast cancer treatment, BMI, post-op swelling/lymphoedema. J Lymphoedema 3(2):38-44
34. Armer JM, Stewart BR, Shook RP (2009) 30-month post-breast cancer treatment lymphoedema. J Lymphoedema 4(1):14-18
35. Solway S, Beaton DE, McConnell S, Bombardier C (2002) The DASH outcome measure user's manual, 2nd edn. Institute for Work and Health, Toronto
36. Lee TS, Kilbreath SL, Sullivan G, Refshauge KM, Beith JM (2007) The development of an arm activity survey for breast cancer survivors using the Protection Motivation Theory. BMC Cancer 7:75. doi:10.1186/1471-2407-7-75 (Pubitemid 46850940)
37. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G (1997) Reliability and validity of the functional assessment of cancer therapy-breast quality-oflife instrument. J Clin Oncol 15(3):974-986 (Pubitemid 27106280)
38. Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, Leight G, Winer EP (1998) Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer 83(7):1362-1368. doi:10.1002/ (SICI)1097-0142(19981001)83:7\1362:AID-CNCR13[3.0. CO; 2-2 (Pubitemid 28460087)
39. Hack TF, Cohen L, Katz J, Robson LS, Goss P (1999) Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17(1):143-149 (Pubitemid 29022387)
40. Kiluk JV, Santillan AA, Kaur P, Laronga C, Meade T, Ramos D, Cox CE (2008) Feasibility of sentinel lymph node biopsy through an inframammary incision for a nipple-sparing mastectomy. Ann Surg Oncol 15(12):3402-3406. doi:10.1245/s10434-008-0156-z
41. Baron RH, Fey JV, Raboy S, Thaler HT, Borgen PI, Temple LK, Van Zee KJ (2002) Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncol Nurs Forum 29(4):651-659. doi:10.1188/02.ONF.651-659
42. Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, Krag DN, Christian NJ, Costantino JP, Wolmark N, Ganz PA (2010) Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: national surgical adjuvant breast and bowel project phase III protocol B-32. J Clin Oncol 28(25):3929-3936. doi:10.1200/JCO.2010.28.2491
43. Leidenius M, Leivonen M, Vironen J, von Smitten K (2005) The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 92(1):23-31. doi:10.1002/jso.20373 (Pubitemid 41416425)
44. Soran A, Falk J, Bonaventura M, Keenan D, Ahrendt G, Johnson R (2007) Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience. Ann Surg Oncol 14(2):646-651. doi:10.1245/s10434-006-9264-9 (Pubitemid 46175310)
45. Boughey JC, Cormier JN, Xing Y, Hunt KK, Meric-Bernstam F, Babiera GV, Ross MI, Kuerer HM, Singletary SE, Bedrosian I (2007) Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer 110(11):2542-2550. doi:10.1002/cncr.23067 (Pubitemid 350174942)
46. Zhou WB, Liu XA, Dai JC, Wang S (2011) Meta-analysis of sentinel lymph node biopsy at the time of prophylactic mastectomy of the breast. Can J Surg 54(5):300-306. doi:10.1503/ cjs.006010
47. Nasser SM, Smith SG, Chagpar AB (2010) The role of sentinel node biopsy in women undergoing prophylactic mastectomy. J Surg Res 164(2):188-192. doi:10.1016/j.jss.2010.07.020
48. Black D, Specht M, Lee JM, Dominguez F, Gadd M, Hughes K, Rafferty E, Smith B (2007) Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy. Ann Surg Oncol 14(9):2477-2484. doi: 10.1245/s10434-007-9356-1 (Pubitemid 47389556)
49. Perre CI, Hoefnagel CA, Kroon BB, Zoetmulder FA, Rutgers EJ (1996) Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with breast cancer. Br J Surg 83(9):1258 (Pubitemid 26290460)